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Introduction
The retina is a critical part of  the eye that contains abundant 
blood vessels and a variety of  cellular structures. Retinal man-
ifestations of  disease can have serious consequences and lead 
to significant vision loss and blindness. Imaging of  the retina 
plays an important role in the discovery and evaluation of  retinal 
pathophysiology in health and disease. With disease progression, 
imaging plays a critical role in disease diagnosis, monitoring, and 
assessing response to therapy. This review focuses on three novel, 
emerging retinal imaging technologies: optical coherence tomog-
raphy angiography (OCTA), photoacoustic imaging (PAI), and 
molecular imaging (MI). It will be introduced from the following 
aspects: their fundamentals and basic principles, current clinical 
applications in retina, and their limitations and future prospects.
Optical Coherence Tomography Angiography 
(OCTA)
Optical coherence tomography angiography (OCTA) is a novel, 
non-invasive imaging modality. It can simultaneously obtain de-
tailed structural and blood flow data within retinal and choroidal 
vessels. OCTA imaging occurs by motion contrast processing of  
decorrelation signals. In the past, optical coherence tomography 
(OCT), fluorescein angiography (FA), and indocyanine green an-
giography (ICGA) have been established as essential imaging mo-
dalities in the diagnosis and management of  retinal diseases. OCT 
can non-invasively image intraocular structures in vivo with a high 
resolution approaching that of  histological sections. OCT has ad-
vantages for the diagnosis of  macular diseases such as macular 
hole, macular edema, and epiretinal membrane. It does not re-
quire invasive injections, and it is easier and faster to acquire. But 
since the similar reflectivities, OCT may not distinguish choroidal 
neovascularization (CNV) from subretinal fibrosis, fibrotic pig-
ment epithelial detachments (PED), hemorrhage, or adjacent ret-
inal tissue, such as retinal pigment epithelium (RPE) and Bruch’s 
membrane. FA originated in the 1960s and is the gold standard 
for retinal vascular imaging. FA uses several fluorescent patterns, 
such as leakage, pooling, staining, blockage, window defects, and 
the dye transit time to show vascular dynamic changes[1]. Where-
as the choroidal vascular wall is permeable to fluorescein, the cho-
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roidal vasculature is not freely permeable to ICG, so ICGA can 
be used to image the choroid, neovascular membranes beneath 
the RPE, and polypoidal choroidal vasculopathy (PCV). Howev-
er, both FA and ICGA involve invasive injections of  exogenous 
dyes, and the dyes pose risks ranging from nausea and vomiting 
to allergic reactions, including anaphylaxis and rarely death. The 
three kinds of  imaging methods have their drawbacks that will 
limit their application. For the patients that can not tolerate intra-
venous dye injection or those who require frequent examinations, 
it would be beneficial to use a non-invasive technique to visualize 
retinal and choroidal vessels. OCTA is the technique that acquires 
volumetric angiographic information without using exogenous 
dye.
Principles Of  OCTA
OCTA provides vascular imaging via motion contrast processing 
of  decorrelation signals. The variable signal intensities and am-
plitudes, which obtained from sequential B scans in the posterior 
segment area, generate decorrelation signals. Through software 
removal of  bulk axial movement, the remaining difference in 
signal amplitude between sequential B scans is due to erythro-
cyte flow in the vasculature. Therefore, the retina and choroid 
functional vascular information is produced by the difference of  
signals and amplitudes, which can be processed by multiple algo-
rithms. 
Three main classes of  imaging algorithms exist: phase based, 
amplitude based, and complex algorithm based. Nowadays, the 
split-spectrum amplitude decorrelation angiography (SSADA) is 
the most common algorithm [2], which is used with the spectral 
domain OCTA (SD-OCTA) machine. Using the SSADA OCTA 
algorithm, images will be provided with a higher quality via opti-
mization of  the signal-to-noise ratio of  flow detection.
Since the retina is a laminar structure with corresponding stratifi-
cation of  blood supply, en-face visualization of  the correspond-
ing vascular supply for the layer provides the best visualization of  
the vascular layers. Based on different software processes, en-face 
zones was been divided into 3 or 4 parts. The 3 parts include: 
the inter retina, which is defined from the internal limiting mem-
brance (ILM) to the outer boundary of  the outer plexiform layer 
(OPL); the outer retina, that is defined from the outer OPL to 
the Bruch’s membrane (BM); and the choroidal layer is defined as 
below BM. The 4 en-face zones contain: the superficial plexus, the 
deep plexus, the outer retina, and the choroicapillaries.
Applications Of  OCTA
Spaide et al.,[3] demonstrated that with detection of  12 eyes, fluo-
rescein angiography couldn’t visualize the radial peripapillary cap-
illary network around the optic nerve head completely, whereas the 
network was visualized by the SSADA scans. Yali Jia et al.,[4] used 
a highspeed (100,000 A-scans/sec) 1050 nm wavelength swept-
source optical coherence tomography (SS-OCT) to scanned five 
neovascular AMD and five normal eyes. Flow was detected by the 
SSADA algorithm. They determined that OCTA provided more 
distinct vascular network patterns that were less obscured by sub-
retinal hemorrhage. OCTA acquires depth-resolved information 
and detailed images of  CNV in neovascular AMD. Waheed et 
al.,[5] compared visualization of  CNV using SD-OCTA (oper-
ating at 840nm wavelength) vs SS-OCTA (operating at 1050 nm 
wavelength). They both used the two systems to measure type 1, 
type 2, and mixed type CNV in exudative age-related macular de-
generation (AMD). Due to the longer wavelength of  SS-OCTA, 
it yielded significantly larger CNV areas than SD-OCTA. SS-OC-
TA may be able to overcome signal attenuation, such as from the 
RPE, media opacities, and any overlying hemorrhage. Takase et 
al., [6] detected the area of  the foveal avascular zone (FAZ) by en- 
face OCTA (AngioVue, Avanti OCT; Optovue), and then evalu-
ated the diferences between healthy and diabetic eyes. They found 
that the FAZ area in the deep plexus layer was significantly larger 
in diabetic eyes than in healthy eyes. Therefore they concluded 
that en-face OCTA is a useful non-invasive screening tool for 
detecting early microcirculatory disturbance in diabetic patients. 
Samara et al., [7] measured the vascular density and FAZ area in 
deep and superficial retinal vascular networks using OCTA in 17 
patients with branch retinal vein occlusion (BRVO). The BRVO 
eyes were compared with their fellow eyes, and the study deter-
mined that the superficial and deep vascular density in BRVO eyes 
measured by quantitative OCTA was decreased. The mean FAZ 
area in BRVO eyes was significantly lower in the deep vascular 
network when compared to the fellow eyes. Moreover, vascular 
density and FAZ area appear to correlate with visual function. 
Adeleh et al., [8] evaluated the association between vessel density 
and severity of  visual field loss in primary open-angle glaucoma 
(POAG). They imaged 153 eyes, which contain 31 normal eyes, 48 
glaucoma suspects, and 74 glaucoma eyes, by OCTA (Angiovue; 
Optovue, Fremont, CA). The study concluded that decreased ves-
sel density was significantly associated with the severity of  visual 
field damage independent of  the structural loss. So OCTA is a 
promising technology in glaucoma management.
The above application of  OCTA has shown promise in the evalu-
ation of  common ophthalmologic diseases such as AMD, diabet-
ic retinopathy, retinal vascular occlusions (RVO) and glaucoma. 
OCTA provide an available and noninvasive device to monitoring 
CNV in AMD [9, 10] and other related disorders. It is helpful to 
image the FAZ in eyes with unexplained visual loss and can pro-
vide information of  the deep retinal capillary (Figure 1).
Limitation And Prospects
Despite potential benefits and broad application of  OCTA in var-
ious retinal diseases [11], OCTA exist some other unavoidable 
limitations. In the past, the major and most reported limitation 
is several type of  artifacts that require careful interpretation. 
Although different methods, such as eye tracking software and 
projection-resolved OCTA, have been employed to help remove 
these artifacts, correction of  artifacts entirely is also challenging. 
Another limitation includes the inability to show leakage [12] and 
a limited view of  microaneurysms, both of  which give us very 
important information in disease analysis. In addition, imaging a 
larger field of  view [13] and monitoring slow flow (e.g. microan-
eurysms) more sensitively are important areas for future develop-
ment. OCTA is a novel and evolving field. It will be advantageous 
in improving patient care and reducing the morbidity of  retinal 
diseases through earlier detection and intervention [10, 11].
Photoacoustic Imaging (PAI)
Photoacoustic imaging is a promising imaging technique that is 
particularly useful for imaging deep retinal and choroidal struc-
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tures without compromising the spatial resolution [14]. It has 
been demonstrated to image hemoglobin, melanin, and exoge-
nous contrast agents [15]. OCT and ultrasound (US) techniques 
are widely used methods for diagnostic imaging of  the eye. They 
detect discontinuities in optical refractive index and acoustic im-
pedance, respectively. PAI depicts optical absorption, which is in-
dependent of  tissue characteristics imaged by OCT and US.
Principle Of  PAI
PAI is based on optical excitation and ultrasonic detection. A 
short pulse laser (nanosecond pulse duration) illuminates and ex-
cites the eye. The retina of  the eye absorbs some of  the delivered 
laser energy, generates heat, undergoes transient thermoelastic 
expansion, and produces ultrasonic signal. An ultrasound trans-
ducer is focused on the retinal surface and detects ultrasonic sig-
nals, which are then imaged for both anatomic PAI and functional 
analysis [16-18].
Applications Of  PAI
Since 2010, several groups have built ocular PA imaging systems 
and reported imaging for the eye. Our group performed PAI of  
an enucleated pig eye and the eye of  living rabbits. We acquired 
3D images of  the posterior pole (retina, choroid, optic nerve) of  
the rabbit eye by ultrasound and photoacoustic imaging [18-20]. 
Silverman et al., [21] imaged fresh ex vivo pig eyes by PAI and US. 
They demonstrated choroidal/scleral images, and the PAI image 
shows sharp depiction of  the choroidal surface but with limited 
penetration due to the strong absorption of  the green laser by 
melanin. This article demonstrated high-resolution PAI of  ex vivo 
eyes. Zhang et al., [22] showed a system simultaneously acquired 
photoacoustic ophthalmoscopy (PAOM) and OCT B-scan images 
of  eyes. They demonstrate contrast mechanism of  PAOM is that 
the stronger the optical absorption, the stronger the generated 
ultrasonic signals. They demonstrate that the hemoglobin in the 
blood vessels and the melanin in the RPE cells are strong ab-
sorbers of  the illuminating light, in contrast other retinal tissues 
have very low optical absorption. Due to the difference of  optical 
absorption, we can get the functional and anatomical imaging of  
the blood vessels and the RPE. 
Moreover, PAI as an ophthalmic imaging modality is based on 
optical absorption, it can be integrated with other well-established 
clinical ophthalmic imaging techniques in order to acquire more 
detailed anatomic and functional evaluation of  the eye by multi-
ple optical contrasts [17, 23]. Song et al., [24] developed a retinal 
imaging platform integrating PAOM with scanning laser ophthal-
moscopy (SLO), SD-OCT, and FA. In this system, all the imaging 
modalities shared the same optical scanning and delivery mecha-
nisms, which enable registered retinal imaging from all the modal-
ities. They use this system to achieve high-quality in vivo images 
in rat eyes. Liu et al., [25] successfully measured retinal oxygen 
saturation using an integrated PAOM and OCT system. The pro-
posed imaging modality can be a powerful tool for the investiga-
tion of  the pathophysiology of  retinal diseases and retinal disease 
detection in clinical practice. We have also recently developed a 
multimodal system which contains PAI, OCT, and fluorescence 
microscopy which we are using to image the vasculature in vivo of  
rabbit and mice eye [26-30] (Figure 2).
Limitation And Prospects
PAI is expected to find broad applications in retinal diseases. It 
has provided us with abundant experience and knowledge in pre-
clinical studies [31]. PAI has been able to map the hemoglobin 
oxygen saturation in retinal vessels, which is critical in studying 
the physiology and pathology of  various blinding diseases such 
as diabetic retinopathy (DR) and neovascular AMD. Multimodal 
imaging systems will likely play an important role in the devel-
opment of  PAI in future, especially to promote the evaluation 
of  PAI compared with other modalities in both clinical use and 
fundamental investigation in detecting and management blinding 
diseases [23, 32, 33]. Future improvements in laser sources and 
detectors, image processing software, and eye tracking to reduce 
the influence of  eye movement will open up opportunities for 
PAI in retinal diseases detection and treatment methods.
Figure 1. Vessel density map of  the retinal nerve fiber layer showing microvasculature in healthy (most dense), mild, moder-
ate, and severe glaucoma (least dense) eyes. Top: Vessel density extracted map with elliptical circumpapillary (circumpapil-
lary vessel density) measurement region defined. Second row: Area vessel density color-coded map. Bottom row: Standard 
automated perimetry visual field results showing corresponding visual field defects [8].
Healthy Mild Glucoma Moderate Glaucoma Severe Glaucoma
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Molecular Imaging
Molecular imaging of  the eye plays an increasingly powerful role 
in ocular therapeutic discovery in preclinical processes. The imag-
es of  the retina will be at the cell and molecular level. Molecular 
imaging can be used both in basic research and in clinical ophthal-
mology. The developments have important implications in early 
disease detection, treatment surveillance, and targeted therapy in 
a range of  pathologies.
Principle Of  MI
Molecular imaging can take place using multiple imaging systems 
and some special biomarkers [34]. The modalities for MI may in-
clude PAI, optical imaging, ultrasound, OCT, and fluorescence 
to obtain fundamental images at the cellular and molecular level. 
Biomarkers are important as imaging tools and targets, such as 
intrinsic imaging contrast in tissue, targeted injectable contrast 
agents, reporter gene imaging and cell labelling, antibody label-
ling, protein expression, enzyme activity, nanoparticles, and apop-
tosis [35].
Applications Of  MI
MI can precede retinal structural changes in a number of  diseases 
lead to vision loss, including AMD, glaucoma, diabetic retinopa-
thy, and retinopathy of  prematurity [34, 36, 37]. King et al., [38] 
suggests that ROS a good early indicator of  the changes of  dis-
ease-related in the RPE. Takeda et al., [39] indicates that the C-C 
chemokine receptor 3 (CCR3) is a possible target for AMD diag-
nosis and therapy. CCR3 can play a role as a potentially important 
biomarker of  CNV in AMD. Tsuda et al., [37] used a cell-imper-
meable, fluorescent nucleic acid dye compound, SYTOX orange 
(SO) as the biomarker. Confocal scanning laser ophthalmoscope 
(cSLO) is used as the imaging modality. In a murine modal with 
optic nerve crushed (ONC), SO was injected into the vitreous 
cavity. After ten minutes, retinal ganglion cells (RGC) death was 
visualized with cSLO in vivo. Real time imaging with SO was able 
to quickly quantify RGC death. Evans et al., [40] discovered HY-
POX-1 and HYPOX-2 are a promising step toward translation of  
hypoxia-sensitive molecular imaging agents in preclinical animal 
models and patients. Dearling et al., [41] reviewed the use of  mo-
lecular imaging to measure in vivo distribution of  nanoparticles, 
and summerized that nanoparticles are an important and prom-
ising target for developing the application of  molecular imaging. 
Thus molecular imaging of  the retina is poised to play an import-
ant role in disease diagnosis and monitoring, as well as assessment 
of  therapeutic efficacy.
Limitation And Prospects
Molecular imaging act as a great powerful method to translate 
basic science into clinical application. It provides a way to evaluate 
and quantify pathways in both animal modals and patients. In ad-
dition, molecular imaging can be used in targeted, individualized 
therapies and pharmacodynamic measurements for optimal dos-
ing [23]. Molecular imaging holds significant promise as a novel 
tool as further biomarkers are developed.
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